A Study of Isoquercetin in People With Ovarian Cancer
Phase 2 Recruiting
90 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
Study of INCB123667 in Subjects With Advanced Solid Tumors
Phase 1 Recruiting
604 enrolled
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Phase 1 Recruiting
27 enrolled
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Phase 2 Recruiting
140 enrolled
OVATION-3
Phase 3 Recruiting
500 enrolled
MUIR
Phase 1 Recruiting
172 enrolled
ERADIC8
Phase 1/2 Recruiting
120 enrolled
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 1/2 Recruiting
71 enrolled
Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)
Phase NA Recruiting
98 enrolled
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Phase 1/2 Recruiting
22 enrolled
DUAL-OV-CAR-NK
Phase 1/2 Recruiting
36 enrolled
DO-01
Phase 3 Recruiting
582 enrolled
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Phase 1 Recruiting
60 enrolled
IMPrOVE
Recruiting
300 enrolled
FOCUS / KOV-04
Phase 3 Recruiting
520 enrolled
Melisa-II
Phase NA Recruiting
62 enrolled
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Phase NA Recruiting
20 enrolled
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Phase 1 Recruiting
90 enrolled
TREVI-OC-01
Phase 3 Recruiting
1,100 enrolled
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Phase 2 Recruiting
230 enrolled
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
Phase NA Recruiting
94 enrolled
Study of AVZO-021 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
430 enrolled
PlatinOv
Phase NA Recruiting
600 enrolled
NEODOC
Phase 1/2 Recruiting
10 enrolled
IOSI-GYNE-001
Recruiting
74 enrolled
WoO
Phase 2 Recruiting
60 enrolled
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Recruiting
250 enrolled
KOV-02S
Phase 2 Recruiting
80 enrolled
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 Recruiting
345 enrolled
ORACLE
Recruiting
2,020 enrolled
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer
Phase 3 Recruiting
384 enrolled
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Phase 1 Recruiting
292 enrolled
Genetic Testing Decision Aid
Phase NA Recruiting
350 enrolled
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 Recruiting
70 enrolled
ABILITY-1
Phase 1/2 Recruiting
115 enrolled
ORACLE
Recruiting
168 enrolled
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Phase NA Recruiting
35 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
REMISSION
Recruiting
1,500 enrolled
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Phase 1 Recruiting
50 enrolled
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Recruiting
6,000 enrolled
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
Phase 2 Recruiting
40 enrolled
BCBOvaire
Phase NA Recruiting
300 enrolled
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Phase 3 Recruiting
538 enrolled
LEPRE
Phase 3 Recruiting
132 enrolled
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
Phase NA Recruiting
157 enrolled
PRODIGYN
Recruiting
120 enrolled
T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
Phase 1/2 Recruiting
70 enrolled
A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
Phase 1 Recruiting
70 enrolled